- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Global Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
821
0 new
Companies which are more than 50% undervalued based on analyst price target.
821 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BIIB | US$146.23 | 1.8% | -41.0% | US$21.0b | US$228.33 | PE13.2x | E10.3% | n/a | ||
SMMT | US$21.64 | -8.0% | 452.0% | US$17.3b | US$33.08 | PB36.4x | E38.9% | n/a | ||
MRNA | US$41.04 | -3.2% | -58.6% | US$15.7b | US$62.96 | PS3.1x | E20.5% | n/a | ||
A196170 | ₩362,000.00 | 4.3% | 407.0% | ₩19.3t | ₩565,000.00 | PS259.4x | E140.6% | n/a | ||
GMAB | DKK 1,410.00 | -6.7% | -26.2% | DKK 88.6b | DKK 2,292.13 | PE19x | E21.4% | n/a | ||
BMRN | US$63.88 | 2.7% | -28.0% | US$12.1b | US$97.16 | PE37.8x | E24.1% | n/a | ||
PCVX | US$91.95 | 2.2% | 21.7% | US$11.1b | US$149.89 | PB3.4x | E27.1% | n/a | ||
SRPT | US$114.44 | -3.9% | -6.8% | US$11.0b | US$185.16 | PE89.7x | E29.8% | n/a | ||
300122 | CN¥24.09 | -0.2% | -46.4% | CN¥57.7b | CN¥36.39 | PE15.6x | E32.0% | 3.3% | ||
ASND | US$127.30 | -0.1% | -10.1% | US$7.6b | US$193.15 | PS22.3x | E57.8% | n/a | ||
RVMD | US$43.07 | 4.7% | 52.4% | US$7.6b | US$73.43 | PS10726.6x | E19.8% | n/a | ||
300896 | CN¥170.02 | -0.8% | -12.1% | CN¥51.2b | CN¥266.90 | PE25.3x | E16.3% | 0% | ||
1801 | HK$33.05 | 4.4% | 0.2% | HK$54.1b | HK$54.61 | PS6.8x | E44.2% | n/a | ||
LEGN | US$37.22 | -1.2% | -33.8% | US$6.6b | US$79.83 | PS13.1x | E56.5% | n/a | ||
1093 | HK$4.46 | 2.1% | -23.5% | HK$51.3b | HK$7.11 | PE9.3x | E1.7% | 7.2% | ||
1177 | HK$2.82 | -1.7% | -3.1% | HK$51.3b | HK$4.49 | PE22.3x | E12.8% | 2.1% | ||
002422 | CN¥28.13 | -1.0% | 21.7% | CN¥44.6b | CN¥43.29 | PE15.1x | E10.6% | 1.8% | ||
CYTK | US$49.97 | 4.4% | -38.5% | US$5.7b | US$81.61 | PS1832x | E43.8% | n/a | ||
GRF | €8.40 | -1.3% | -16.5% | €5.3b | €16.32 | PE35.4x | E30.3% | n/a | ||
IONS | US$33.32 | -3.3% | -34.6% | US$5.2b | US$61.32 | PS6.6x | E40.4% | n/a | ||
RARE | US$43.40 | -3.2% | -1.6% | US$3.9b | US$91.80 | PS7.7x | E56.4% | n/a | ||
RNA | US$31.92 | 6.1% | 161.0% | US$3.8b | US$67.91 | PS376.4x | E34.3% | n/a | ||
BHVN | US$39.00 | -4.2% | -13.3% | US$3.8b | US$65.29 | PB12.5x | E29.0% | n/a | ||
VKTX | US$33.69 | -3.6% | 40.7% | US$3.7b | US$110.00 | PB4.1x | E21.8% | n/a |